NCT03782298

Brief Summary

Safety and performance of the study devices in extremities up to 12 months post-surgery

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
140

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2019

Shorter than P25 for all trials

Geographic Reach
2 countries

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 6, 2018

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 20, 2018

Completed
3 months until next milestone

Study Start

First participant enrolled

March 12, 2019

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 10, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 10, 2019

Completed
5 years until next milestone

Results Posted

Study results publicly available

September 24, 2024

Completed
Last Updated

October 1, 2024

Status Verified

November 1, 2021

Enrollment Period

7 months

First QC Date

November 6, 2018

Results QC Date

September 19, 2023

Last Update Submit

September 27, 2024

Conditions

Keywords

DynomiteSpyromiteRaptormiteFootAnkleWristHandElbowFootprint

Outcome Measures

Primary Outcomes (1)

  • Number of Participants With Clinical Success of the Study Devices in the Extremity Over a Time Period of 6 Months After Intervention

    Clinical success was defined as extremity repairs without signs of device failure and/or re-intervention as assessed by the surgeon. Specifically, clinical success was considered "Yes" based on the following 3 main criteria: * no inflammatory or allergic response * no device-related adverse event (AE) * no device deficiencies (DDs) leading to revision surgery (re intervention) on the index extremity

    6 months

Secondary Outcomes (1)

  • Number of Participants With Clinical Success of the Study Devices in the Extremity Over a Time Period of 12 Months After Intervention

    12 months

Other Outcomes (2)

  • Visual Analog Scale (VAS) - Pain

    6 and 12 months

  • Count of Participants With Range of Motion (ROM) Full Functional Arc

    6 and 12 months

Interventions

PEEK Suture Anchors, which include: * SPYROMITE™ 2.0 PK Suture Anchor with Needles * DYNOMITE™ 2.0 PK Suture Anchor with Needles * RAPTORMITE™ 3.0 Suture Anchor with Needles * FOOTPRINT™ Ultra PK SL Suture Anchor

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Subjects who have undergone extremity joint repair using the study devices, PEEK Anchors (DYNOMITE, SPYROMITE, RAPTOMITE, FOOTPRINT Ultra PK SL)

You may qualify if:

  • Subjects who have undergone extremity joint repair using the study devices.
  • Subjects aged 18 years and older at the time of surgery.

You may not qualify if:

  • Subject is entered in another investigational drug, biologic, or device study or has been treated with an investigational product within 12 months post-operative.
  • Subjects who are \< 3 months post-operative

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

OrthoCarolina

Charlotte, North Carolina, 28207, United States

Location

Precision Orthopaedic Specialties, Inc.

Chardon, Ohio, 44024, United States

Location

Foot and Ankle Associates of North Texas-Grapevine

Grapevine, Texas, 76051, United States

Location

Fowler Kennedy Sport Medicine Clinic

London, Ontario, N6A 3K7, Canada

Location

Results Point of Contact

Title
Judith Horner
Organization
Smtih + Nephew, Inc

Study Officials

  • Judth Horner

    Smith & Nephew, Inc.

    STUDY CHAIR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
LTE60
Restrictive Agreement
Yes

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 6, 2018

First Posted

December 20, 2018

Study Start

March 12, 2019

Primary Completion

October 10, 2019

Study Completion

October 10, 2019

Last Updated

October 1, 2024

Results First Posted

September 24, 2024

Record last verified: 2021-11

Data Sharing

IPD Sharing
Will not share

Locations